Ovarian genes;Gènes de l'ovaire

Gynecologie Obstetrique et Fertilite

Volumn 30, Issue 10, 2002, Pages 827-830

  Christin Maitre S ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Apoptosis; Chemotherapy; FSH; Menopause; Ovary; Turner

Indexed keywords

FOLLITROPIN;

APOPTOSIS; ATAXIA TELANGIECTASIA; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CHEMOTHERAPY; CONFERENCE PAPER; DNA MODIFICATION; GALACTOSEMIA; GDF9 GENE; GDF9B GENE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC REGULATION; HUMAN; HUMAN CELL; MENOPAUSE; OVARY FOLLICLE; OVARY FOLLICLE MATURATION; PREMATURE OVARIAN FAILURE; RECEPTOR GENE; SMOKING; TURNER SYNDROME;

EID: 0036812072     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(02)00449-6     Document Type: Conference Paper

References (13)

1. Aittomäki K, Dieguez L, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, et al. Mutation in the Follicle-Stimulating Hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995;82:959-67.
2. Abel M, Wootton A, Wilkins V, Huhtaniemi I, Knight P, Charlton H. The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. Endocrinology 2000;141:1795-803.
3. Danilovich N, Babu P, Xing W, Gerdes M, Krishnamurthy H, Sairam M. Estrogen deficiency, obesity and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 2000;141:4295-308.
4. Dierich A, Sairam M, Monaco L, Fimia G, Gansmuller A, Lemeur M, Sassone-Corsi P. Impairing follicle-stimulating hormone (FSH) signaling in vivo: Targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. PNAS 1998;95:13612-7.
5. Kumar T, Wang Y, Lu N, Matzuk M. Follicle stimulating hormone is required for ovarian follicle maturation but not for male fertility. Nature Genetics 1997;15:201-6.
6. Aaltonen J, Björses P, Sankuijl L, Perheentupa J, Peltonen L. An autosomal locus causing autoimmune disease: Auto-immune poly-glandular disease type I assigned to chromosome 21. Nature Genetics 1994;8:83-7.
7. Zlotogora J, Sagi M, Cohen T. The blepharophemosis, ptosis, and epicanthus inversus syndrome: Delineation of two types. Am J Hum Genet 1983;35:1020-7.
8. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, et al. The putative fokhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nature Genetics 2001;27:159-63.
9. Perez G, Knudson C, Leykin L, Korsmeyer S, Tilly J. Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nature Medecine 1997;3(11):1228-32.
10. Matikainen T, Perez G, Jurisicova A, Pru J, Schlezinger J, Ryu HY, et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nature Genetics 2001;28:355-60.
11. Kaufman F, Kogut M, Donnell G, Goebelsmann U, March C, Koch R. Hypergonadotropic hypogonadism in female patients with galactosemia. New England Journal of Medicine 1981;304:994-8.
12. Singh R, Carr D. The anatomy and histology of XO human embryos and fetuses. Anat Rec 1966;155:369-83.
13. Ogata T, Matsuo N. Turner syndrome and female sex chromosome aberrations: Deduction of the principal factors involved in the development of clinical features. Hum Genet 1995;95:607-29.